Studies you may discard |
Study # |
Completed Date |
Study Title |
Date OK to discard documents |
1115 |
10/4/2017 |
CHI Echo Analysis |
10/4/2022 |
1115 |
10/4/2017 |
CHI original |
10/4/2022 |
99716 |
4/28/2017 |
Oral Chemo |
4/28/2022 |
99211 |
1/1/2015 |
Quitline Smoking Cessation |
1/1/2020 |
97609 |
9/1/2014 |
Genomics/Breast Biomarker |
9/1/2019 |
99311 |
2/1/2014 |
Memantine for Smoking Cessation |
2/1/2019 |
98110 |
1/1/2014 |
ArginMax and ED |
1/1/2019 |
97509 |
11/1/2013 |
Phase II Study of amodafinil |
11/1/2018 |
71103 |
7/9/2013 |
Phase II Depsipeptide in Sarcomes |
7/9/2018 |
97100 |
8/1/2012 |
Donepezil & Ginkgo in Brain |
8/1/2017 |
91105 |
7/1/2012 |
Phase III Donepezil in Irradiated Brain |
7/1/2017 |
97405 |
8/1/2010 |
Soy Protein and Effexor in Men w PC |
8/1/2015 |
97106 |
6/1/2010 |
Arginmax Improves Sexual Function/QOL in Women |
6/1/2015 |
97211 |
1/8/2013 |
Donepezil in Female Breast Ca |
1/8/2015 |
97202 |
8/1/2009 |
Phase III Study of CoQ10 in Breast Ca |
4/1/2014 |
60A02 |
10/1/2008 |
Phase II of F&V Extracts in Head/Neck Ca |
10/1/2013 |
98301 |
4/1/2008 |
Phase II St. John’s Wort for Hot Flashes |
4/1/2013 |
97102 |
8/1/2007 |
Phase III Comparing Oxandrin and Megace |
8/1/2012 |
97309 |
8/1/2001 |
Yoga |
8/1/2006 |